Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Eli Lilly and Company
Boehringer Ingelheim
Karyopharm Therapeutics Inc
Novartis
Xian-Janssen Pharmaceutical Ltd.
Novartis
Valerio Therapeutics
Valerio Therapeutics
Merck Sharp & Dohme LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Daiichi Sankyo